Hispanic children with high-risk neuroblastoma have worse survival outcomes
Brenton Francisco, MD, presents his research at ASCO finding Hispanic children with high-risk neuroblastoma had worse survival outcomes than other children with the disease, despite receiving treatment on clinical trials with standardized protocols.